Back to search

Article

A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants

2022-01-20

Abstract excerpt

The spike glycoprotein of SARS-CoV-2 engages with human angiotensin-converting enzyme 2 (ACE2) to facilitate infection. Here, we describe an alpaca-derived heavy chain antibody fragment (VHH), saRBD-1, that disrupts this interaction by competitively binding to the spike protein receptor-binding domain. We further generated an engineered bivalent nanobody construct engineered by a flexible linker, and a dimeric Fc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a7c2ccbb-cc21-500d-9f62-9bb33a407285
DOI
10.1101/2022.01.18.476801
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variantsDOI 10.1101/2022.01.18.476801
Select a neighboring publication to make it the new centre.